Previous 10 | Next 10 |
2023-08-18 12:29:37 ET More on Evelo Biosciences Circling Back On Evelo Biosciences Evelo Biosciences enters into termination and surrender pact with Bio-Rad Evelo spikes on $25.5M private placement Evelo slumps ~40% as eczema drug program abandoned after tri...
2023-08-18 10:19:27 ET Gainers: Aditxt ( ADTX ) +50% . AlloVir ( ALVR ) +18% . Agenus ( AGEN ) +7% . Veru ( VERU ) +7% . Akari Therapeutics ( AKTX ) +6% . Losers: Evelo Biosciences ( EVLO ) -37% . Diffusi...
2023-08-15 10:17:36 ET Gainers: Delcath Systems ( DCTH ) +90% . Pharvaris ( PHVS ) +22% . ENDRA Life Sciences ( NDRA ) +14% . NeurAxis ( NRXS ) +12% . SomaLogic ( SLGC ) +12% . Losers: Design Therapeutics ( DSGN ) -6...
2023-08-14 09:46:48 ET Evelo Biosciences press release ( NASDAQ: EVLO ): Q2 GAAP EPS of -$3.78. As of June 30, 2023, cash and cash equivalents were $7.6 million, as compared to cash and cash equivalents of $47.9 million as of December 31, 2022. Fo...
– EDP2939 Phase 2 trial in moderate psoriasis fully enrolled with topline data expected early Q4 2023 – Completed $25.5 Million Private Placement – Restructured and reduced secured debt with Horizon Technology Finance Corporation CAMBRIDGE, Mass., Aug. 14, 2...
2023-08-04 03:32:21 ET Summary Today, we put Evelo Biosciences, Inc. in the spotlight for the first time since June of last year. The stock has delivered a litany of bad news for shareholders in 2023 including discontinuation of development around its previous lead drug candidate....
2023-08-01 10:04:48 ET Gainers: Adamis Pharmaceuticals ( ADMP ) +71% . ABVC BioPharma ( ABVC ) +49% . EQRx ( EQRX ) +18% . Rhythm Pharmaceuticals ( RYTM ) +17% . Esperion Therapeutics ( ESPR ) +6% . Losers: TG Therapeu...
2023-07-24 10:09:58 ET Gainers: Armata Pharmaceuticals ( ARMP ) +19% . Janux Therapeutics ( JANX ) +11% . Amylyx Pharmaceuticals ( AMLX ) +8% . Coherus BioSciences ( CHRS ) +7% . Nuwellis ( NUWE ) +7% . Losers: Kodiak...
Evelo Biosciences, Inc. (NASDAQ: EVLO) is one of today's top gainers. The company's shares are currently up 14.86% on the day to $11.32. Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developi...
2023-07-21 10:22:31 ET Gainers: Quoin Pharmaceuticals ( QNRX ) +45% . Evelo Biosciences ( EVLO ) +24% . Biodexa Pharmaceuticals ( BDRX ) +19% . LifeMD ( LFMD ) +13% . BIMI International Medical ( BIMI ) +12% . Losers: ...
News, Short Squeeze, Breakout and More Instantly...
Evelo Biosciences Inc. Company Name:
EVLO Stock Symbol:
NASDAQ Market:
Evelo Biosciences Inc. Website:
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Friday. Following the market opening Friday, the Dow tr...